Suicide, suicidality and suicide prevention in affective disorders
- PMID: 12956819
Suicide, suicidality and suicide prevention in affective disorders
Abstract
Objective: It is well known that functional psychiatric disorders are one of the main causes of suicidal behaviour. This paper discusses the epidemiology and risk factors of suicidal behaviour in affective disorders and goes on to describe the treatment and prevention of such suicidal behaviour.
Method: A narrative overview of relevant epidemiological and drug studies.
Results: About 60-70% of patients with acute depression experience suicidal ideas. There is a high incidence of suicide (10-15%) in depressive patients. Psychopharmacological treatment with antidepressants and/or mood stabilizers is the most successful approach to avoid the risk of suicidal behaviour. In addition, psychotherapeutic and psychosocial interventions are of importance.
Conclusion: Suicidal behaviour and suicide must be considered when treating patients with affective disorders. The complex causation of suicidality has to be borne in mind when considering methods of suicide prevention. In order to obtain the best results, psychosocial, psychotherapeutic and psychopharmacological approaches should be combined, depending on the risk factors of each individual patient.
Similar articles
-
Antidepressants and suicidal risk.J Clin Psychiatry. 1999;60 Suppl 2:94-9; discussion 111-6. J Clin Psychiatry. 1999. PMID: 10073395 Review.
-
A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP).PLoS Med. 2016 Mar 1;13(3):e1001968. doi: 10.1371/journal.pmed.1001968. eCollection 2016 Mar. PLoS Med. 2016. PMID: 26930055 Free PMC article. Clinical Trial.
-
Identification of suicidal ideation and prevention of suicidal behaviour in the elderly.Drugs Aging. 2002;19(1):11-24. doi: 10.2165/00002512-200219010-00002. Drugs Aging. 2002. PMID: 11929324 Review.
-
[Antidepressants, depression and suicide].Neuropsychopharmacol Hung. 2013 Sep;15(3):157-64. Neuropsychopharmacol Hung. 2013. PMID: 24108180 Review. Hungarian.
-
Atypical antipsychotics and suicide in mood and anxiety disorders.Bipolar Disord. 2003;5 Suppl 2:48-52. doi: 10.1111/j.1399-2406.2003.00062.x. Bipolar Disord. 2003. PMID: 14700012 Review.
Cited by
-
Pathogenetic and therapeutic applications of microRNAs in major depressive disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:341-8. doi: 10.1016/j.pnpbp.2015.02.003. Epub 2015 Feb 14. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 25689819 Free PMC article. Review.
-
MicroRNA-dependent control of neuroplasticity in affective disorders.Transl Psychiatry. 2021 May 3;11(1):263. doi: 10.1038/s41398-021-01379-7. Transl Psychiatry. 2021. PMID: 33941769 Free PMC article. Review.
-
Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States.PLoS Med. 2006 Jun;3(6):e190. doi: 10.1371/journal.pmed.0030190. Epub 2006 Jun 13. PLoS Med. 2006. PMID: 16768544 Free PMC article.
-
Experimental psychiatric illness and drug abuse models: from human to animal, an overview.Methods Mol Biol. 2012;829:31-48. doi: 10.1007/978-1-61779-458-2_2. Methods Mol Biol. 2012. PMID: 22231805 Free PMC article. Review.
-
Psychotic spectrum symptoms across the lifespan are related to lifetime suicidality among 147 patients with bipolar I or major depressive disorder.Ann Gen Psychiatry. 2016 Jun 21;15:15. doi: 10.1186/s12991-016-0101-7. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 27330540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical